Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice
Open Access
- 20 May 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Abstract
In anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) and systemic lupus erythematosus (SLE), glomerulonephritis is a severe kidney complication driven by immune cells, including T cells. However, the mechanisms underlying T cell activation in these contexts remain elusive. Here we report that in patients with AAV and SLE, type I interferon (IFN-I) induces T cell differentiation into interferon-stimulated genes-expressing T (ISG-T) cells, which are characterized by an elevated IFN-I signature, an immature phenotype, and cytotoxicity in inflamed tissue. Mechanistically, IFN-I stimulates the expression of interferon regulatory factor 7 (IRF7) in T cells, which in turn induces granzyme B production. In mice, blocking IFN-I signaling reduces IRF7 and granzyme B expression in T cells, thus ameliorating glomerulonephritis. In parallel, spatial transcriptomic analyses of kidney biopsies from patients with AAV or SLE reveal an elevated ISG signature and the presence of ISG-T cells in close proximity to plasmacytoid dendritic cells, the primary producers of IFN-I. Our results from both patients and animal models thus suggest that IFN-I production in inflamed tissue may drive ISG-T cell differentiation to expand the pool of cytotoxic T cells in autoimmune diseases.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 1192, SFB 1192)
This publication has 77 references indexed in Scilit:
- Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated GlomerulonephritisThe Journal of Immunology, 2009
- Netting neutrophils in autoimmune small-vessel vasculitisNature Medicine, 2009
- IRF7 activation by Epstein–Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3Proceedings of the National Academy of Sciences, 2008
- Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritisArthritis & Rheumatism, 2007
- T Cells in Crescentic GlomerulonephritisJournal of the American Society of Nephrology, 2006
- IRF-7 is the master regulator of type-I interferon-dependent immune responsesNature, 2005
- Anti-CD8 Monoclonal Antibody Therapy Is Effective in the Prevention and Treatment of Experimental Autoimmune GlomerulonephritisJournal of the American Society of Nephrology, 2002
- Multiple Regulatory Domains Control IRF-7 Activity in Response to Virus InfectionJournal of Biological Chemistry, 2000
- Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.1998
- The pCL vector system: rapid production of helper-free, high-titer, recombinant retrovirusesJournal of Virology, 1996